Intrinsic Value
Alnylam Pharmaceuticals, Inc. (ALNY)
$149.45
-4.94 (-3.20%)
Enterprise Value | -1,149,349.36 |
---|---|
Net Debt | 1,869.94 |
Equity Value | -1,151,219.29 |
Shares Outstanding | 124.91 |
Equity Value Per Share | -9,216.69 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt